ARCHIVES

FDA Vs. NCI: Nothing Has Changed; Chabner “Frustrated” By Flutamide Delay

This article is from The Cancer Letter archive.

Vol. 14 No. 41 | October 21, 1988

Download PDF Visit The Full Archive

Related Articles

Generic Paclitaxel Approval Withstands Court Challenge.

May 4, 2001

Long-Term Estrogen Use May Increase Ovarian Cancer Risk

April 27, 2001

NCAB Committee Close To Definition Of QRA

February 11, 1983

NCCS Networker Volume 6 Issue 1, Winter 1992

January 13, 1992

Duke Promised $11.5M For Eye, Lung Research.

March 8, 2002

Mayer Will Emphasize Rehab Research While Serving On NCAB

May 24, 1991